title: Liver transplantation for fulminant hepatic failure without venovenous bypass and without portacaval shunting.
abstract: Preservation of the caval vein during liver transplantation (OLT) has gained wide acceptance but portosystemic bypass or temporary portocaval shunt is still believed to be indicated in patients with fulminant hepatic failure. Herein we have described our initial experience with piggyback OLT without venovenous bypass and without portocaval shunting in five such patients. Division of the portal vein was always delayed until the native liver was completely dissected off the caval vein. The donor hepatic artery was anastomosed to the recipient aorta via an iliac interposition graft placed in the supraceliac position in two and at an infrarenal site in three patients. The ahepatic phase urinary output was low in the two patients in whom we applied supraceliac cross-clamping of the aorta. The mean ahepatic phase was 53 (45 to 67) minutes in four recipients who remained hemodynamically stable throughout surgery and prolonged to 5 hours in one patient due to a complicated supraceliac aortic anastomosis. Its repair resulted in hemodynamic instability, multiorgan failure, and death at 4 days following OLT. Four (80%) patients are alive in good condition with normal liver function after a mean of 12 (5 to 25) months of follow-up. In summary, liver transplantation for fulminant hepatic failure may be safely performed without venovenous bypass and without temporary portocaval shunting if the ahepatic phase is minimized and portal flow to the liver maintained up to the moment of hepatic excision. Arterial anastomosis with the supraceliac aorta prolongs the ahepatic phase and may impair kidney function: therefore, it should be avoided in these patients.
authors.affiliation: Department of Hepatobiliary Surgery and Liver Transplantation, Marie Curie Hospital, ul. Arkonska 4, 71-455 Szczecin, Poland. maciejwojcicki@hotmail.com
authors.forename: M
authors.initials: M
authors.lastname: Wojcicki
authors.forename: K
authors.initials: K
authors.lastname: Jarosz
authors.forename: M
authors.initials: M
authors.lastname: Czuprynska
authors.forename: J
authors.initials: J
authors.lastname: Lubikowski
authors.forename: S
authors.initials: S
authors.lastname: Zeair
authors.forename: J
authors.initials: J
authors.lastname: Bulikowski
authors.forename: M
authors.initials: M
authors.lastname: Gasinska
authors.forename: J
authors.initials: J
authors.lastname: Andrzejewska
authors.forename: T
authors.initials: T
authors.lastname: Surudo
authors.forename: J
authors.initials: J
authors.lastname: Myśliwiec
mesh_terms: D000328:Adult; D001794:Blood Pressure; D006339:Heart Rate; D006440:Hemofiltration; D006801:Humans; D017114:Liver Failure, Acute / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D011167:Portacaval Shunt, Surgical; D011169:Portal Vein; D011517:Prothrombin Time; D012189:Retrospective Studies; D016896:Treatment Outcome